BlackRock Fund Advisors’s Anixa Biosciences ANIX Stock Holding History

BlackRock Fund Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12K	Buy	2,215 +540	+32%	+$3K	﹤0.01%	3939
2016 Q3	$7K	Buy	1,675 +201	+14%	+$670	﹤0.01%	4006
2016 Q2	$5K	Buy	1,474 +128	+10%	+$390	﹤0.01%	4083
2016 Q1	$4K	Buy	1,346 +308	+30%	+$884	﹤0.01%	4114
2015 Q4	$3K	Buy	+1,038	New	+$3.64K	﹤0.01%	4213

Other funds holding ANIX

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DIA

Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

BlackRock Fund Advisors's ANIX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Anixa Biosciences (ANIX) stake by 32% in Q4 2016, buying an estimated $3K and bringing the position to 2,215 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3939.

BlackRock Fund Advisors first reported a position in ANIX in Q4 2015 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold ANIX as of Q4 2016.

BlackRock Fund Advisors held 2,215 shares of Anixa Biosciences worth $12K as of Q4 2016.
BlackRock Fund Advisors bought 540 Anixa Biosciences shares in Q4 2016, an estimated $3K.
Anixa Biosciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3939 holding.
BlackRock Fund Advisors first reported a position in Anixa Biosciences in Q4 2015 and has held it in 5 quarters since.
13 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.